AI
Beneficient Closes $7.44 Million GP Primary Capital Transaction
DALLAS, July 13, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of a $7.44 million primary capital commitment in Quartus AI Fund II LP (the “Fund”), a fund managed by Quartus Capital Partners LLC (“Quartus”), a New York based investment firm investing in growt
About this update from Beneficient
DALLAS, July 13, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of a $7.44 million primary capital commitment in Quartus AI Fund II LP (the "Fund"), a fund managed by Quartus Capital Partners LLC ("Quartus"), a New York based investment firm investing in growth stage AI and technology ventures (the "Transaction"). Quartus is led by AI pioneers, technologists, and seasoned operators. The Transaction reflects continued momentum for the Company's GP Primary Commitment Program and further execution of its strategy to provide primary capital solutions to qualifying private investment funds, while marking Beneficient's second GP primary capital transaction this year with an AI-focused fund managed by Quartus. As consideration for the Company's interest in the Fund, the Fund received approximately $7.44 million in stated value of shares of the Company's Resettable Convertible Preferred Stock (the "Preferred Stock"), which is convertible at the election of the holder into shares of the Company's Class A common stock, subject to the terms and conditions of the Transaction documents. The Company's commitment is structured to scale with the Fund's total capital commitments, up to $26.25 million if the Fund achieves its target capital commitments of $150 million. The Transaction is expected to increase the collateral for the Company's ExAlt loan portfolio by approximately $7.44 million of interests in alternative assets and add approximately $7.44 million of tangible book value attributable to the Company's stockholders. Fiscal year to date, the Company's GP primary capital transactions have contributed approximately $17.2 million of aggregate tangible book value attributable to the Company's stockholders. "We are pleased to expand our relationship with Quartus by closing this Transaction with a second AI-focused fund that Quartus manages," said James Silk, Beneficient CEO. "Artificial intelligence continues to be one of the most dynamic and actively expanding areas of the global technology market, and we are excited that our GP Primary Commitment Program provides Beneficient with a pathway to participate in that growth through exposure to differentiated AI-focused private investment funds. The Company will continue to pursue transactions that we believe can drive shareholder value, strengthen the collateral backing our ExAlt loan portfolio, and expand Beneficient's exposure to high-growth areas of the private markets."